These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 19681476)
1. [Antithrombotic therapy in the treatment of STEMI and NSTEMI patients]. Nikolić Heitzler V; Pavlov M; Babić Z; Bulj N Acta Med Croatica; 2009 Feb; 63(1):117-9. PubMed ID: 19681476 [TBL] [Abstract][Full Text] [Related]
2. Results from clinical trials on ST-elevation myocardial infarction in a historic perspective with some pathophysiological aspects. Otterstad JE; Brosstad F Scand Cardiovasc J; 2003 Dec; 37(6):316-23. PubMed ID: 14668180 [TBL] [Abstract][Full Text] [Related]
3. Antithrombotic therapy and the transition to the catheterization laboratory in UA/NSTEMI. Ferguson JJ; Wilson JM; Diez J Minerva Cardioangiol; 2007 Oct; 55(5):529-56. PubMed ID: 17912162 [TBL] [Abstract][Full Text] [Related]
4. Pharmacoinvasive management of acute coronary syndrome: incorporating the 2007 ACC/AHA guidelines: the CATH (cardiac catheterization and antithrombotic therapy in the hospital) Clinical Consensus Panel Report--III. Cohen M; Diez JE; Levine GN; Ferguson JJ; Morrow DA; Rao SV; Zidar JP; ; J Invasive Cardiol; 2007 Dec; 19(12):525-38; quiz 539-40. PubMed ID: 18180524 [TBL] [Abstract][Full Text] [Related]
9. STEMI and NSTEMI: the dangerous brothers. Bode C; Zirlik A Eur Heart J; 2007 Jun; 28(12):1403-4. PubMed ID: 17526505 [No Abstract] [Full Text] [Related]
10. Have we reached the therapeutic ceiling in acute myocardial infarction? Roberts C Crit Care Nurse; 1999 Oct; 19(5 Suppl):7-11. PubMed ID: 10808806 [TBL] [Abstract][Full Text] [Related]
12. Influence of different antiplatelet treatment regimens for primary percutaneous coronary intervention on all-cause mortality. Witkowski A; Maciejewski P; Wasek W; Malek LA; Niewada M; Kaminski B; Drzewiecki J; Kosmider M; Kubica J; Ruzyllo W; Peruga JZ; Dudek D; Opolski G; Dobrzycki S; Gil RJ; Eur Heart J; 2009 Jul; 30(14):1736-43. PubMed ID: 19376786 [TBL] [Abstract][Full Text] [Related]
13. [Antithrombotic treatment in percutaneous transluminal coronary angioplasty]. Brekke M; Kuiper K Tidsskr Nor Laegeforen; 1998 Feb; 118(5):729-32. PubMed ID: 9528370 [TBL] [Abstract][Full Text] [Related]
14. [European Society of Cardiology guidelines on ST-elevation myocardial infarction: what is new?]. De Servi S; D'Urbano M G Ital Cardiol (Rome); 2009 Jul; 10(7):490-2. PubMed ID: 19761104 [No Abstract] [Full Text] [Related]
15. [The region of Karlovac in the urgent PCI network]. Horvat D; Grman J Acta Med Croatica; 2009 Feb; 63(1):99-101. PubMed ID: 19681472 [TBL] [Abstract][Full Text] [Related]
16. Pharmacological and mechanical revascularization strategies in STEMI: integration of the two approaches. Pollack C J Invasive Cardiol; 2008 May; 20(5):231-8. PubMed ID: 18460708 [TBL] [Abstract][Full Text] [Related]
17. [Anticoagulant and thrombolytic agents in acute coronary syndrome]. Saurbier B; Bode C Hamostaseologie; 2005 Nov; 25(4):333-44. PubMed ID: 16395483 [TBL] [Abstract][Full Text] [Related]
18. [Antithrombotics in pre-hospital phase of acute coronary syndromes]. Collet JP; Dumaine R; Ecollan P; Beygui F; Choussat R; Boon G; Payot L; Montalescot G Arch Mal Coeur Vaiss; 2005 Nov; 98(11):1118-22. PubMed ID: 16379108 [TBL] [Abstract][Full Text] [Related]
19. The pharmaco-invasive approach to STEMI: when should fibrinolytic-treated patients go to the "cath lab"? Edmond JJ; Juergens CP; French JK Heart; 2009 Mar; 95(5):358-61. PubMed ID: 18467356 [TBL] [Abstract][Full Text] [Related]